[1] Im HI. Molecular and cellular substrates of neuroinflammation in Alzheimer disease and depression[J]. Int Neurourol J, 2019, 23(Suppl 2):S51-52. [2] Zhou G, Liu S, Yu X, Zhao X, Ma L, Shan P. High prevalence of sleep disorders and behavioral and psychological symptoms of dementia in late-onset Alzheimer disease:a study in Eastern China[J]. Medicine (Baltimore), 2019, 98:e18405. [3] Beard CM, Kokmen E, O'Brien PC, Anía BJ, Melton LJ 3rd. Risk of Alzheimer's disease among elderly patients with anemia:population-based investigations in Olmsted County, Minnesota[J]. Ann Epidemiol, 1997, 7:219-224. [4] Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL, Bush AI; AIBL Research Group. An anemia of Alzheimer's disease[J]. Mol Psychiatry, 2014, 19:1227-1234. [5] Belay E, Miller CP, Kortum AN, Torok-Storb B, Blau CA, Emery DW. A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor[J]. Blood, 2015, 125:1025-1033. [6] Zhao L, He R, Long H, Guo B, Jia Q, Qin D, Liu SQ, Wang Z, Xiang T, Zhang J, Tan Y, Huang J, Chen J, Wang F, Xiao M, Gao J, Yang X, Zeng H, Wang X, Hu C, Alexander PB, Symonds ALJ, Yu J, Wan Y, Li QJ, Ye L, Zhu B. Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells[J]. Nat Med, 2018, 24:1536-1544. [7] Shi Z, Zhang K, Zhou H, Jiang L, Xie B, Wang R, Xia W, Yin Y, Gao Z, Cui D, Zhang R, Xu S. Increased miR-34c mediates synaptic deficits by targeting synaptotagmin 1 through ROS-JNK-p53 pathway in Alzheimer's disease[J]. Aging Cell, 2020, 19:e13125. [8] Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, Fan J, Zhou W, Qiu S, Zhang Y, Dong T, Li N, Jiang Z, Zhu H, Zhang Q, Ma Y, Zhang L, Wang Q, Yu Y, Li N, Cao X. Tumor-induced generation of splenic erythroblast-like Ter-cells promotes tumor progression[J]. Cell, 2018, 173:634-648.e12. [9] Edamitsu T, Taguchi K, Kobayashi EH, Okuyama R, Yamamoto M. Aryl hydrocarbon receptor directly regulates Artemin gene expression[J]. Mol Cell Biol, 2019, 39:e00190-19. [10] Chinese Writing Group on Dementia and Cognitive Impairment;Cognitive Disorders Professioonal Committee, Neurology Branch, Chinese Medical Doctor Association. 2018 Chinese guidelines for the diagnosis and treatment of dementia and cognitive disorders(Ⅱ):guidelines for the diagnosis and treatment of Alzheimer's disease[J]. Zhonghua Yi Xue Za Zhi, 2018, 98:971-977.[中国痴呆与认知障碍写作组, 中国医师协会神经内科医师分会认知障碍疾病专业委员会. 2018中国痴呆与认知障碍诊治指南(二):阿尔茨海默病诊治指南[J]. 中华医学杂志, 2018, 98:971-977.] [11] Estrada-Valencia M, Herrera-Arozamena C, Pérez C, Viña D, Morales-García JA, Pérez-Castillo A, Ramos E, Romero A, Laurini E, Pricl S, Rodríguez-Franco MI. New flavonoid-N, N-dibenzyl (N-methyl) amine hybrids:multi-target-directed agents for Alzheimer's disease endowed with neurogenic properties[J].J Enzyme Inhib Med Chem, 2019, 34:712-727. [12] Llibre-Guerra JJ, Li Y, Schindler SE, Gordon BA, Fagan AM, Morris JC, Benzinger TLS, Hassenstab J, Wang G, Allegri R, Berman SB, Chhatwal J, Farlow MR, Holtzman DM, Jucker M, Levin J, Noble JM, Salloway S, Schofield P, Karch C, Fox NC, Xiong C, Bateman RJ, McDade E. Association of longitudinal changes in cerebrospinal fluid total tau and phosphorylated tau 181 and brain atrophy with disease progression in patients with Alzheimer disease[J]. JAMA Netw Open, 2019, 2:e1917126. [13] Niculescu AB, Le-Niculescu H, Roseberry K, Wang S, Hart J, Kaur A, Robertson H, Jones T, Strasburger A, Williams A, Kurian SM, Lamb B, Shekhar A, Lahiri DK, Saykin AJ. Blood biomarkers for memory:toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs[J]. Mol Psychiatry, 2020, 25:1651-1672. [14] Zhou L, Ma YC, Tang X, Li WY, Ma Y, Wang RL. Identification of the potential dual inhibitor of protein tyrosine phosphatase sigma and leukocyte common antigen-related phosphatase by virtual screen, molecular dynamic simulations and post-analysis[J]. J Biomol Struct Dyn, 2021, 39:45-62. [15] Wu JW, Zhang H, Li WY, Tang X, Li HL, Lu XH, Zheng ZH, Ma Y, Wang RL. Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace approach[J]. J Biomol Struct Dyn, 2020, 38:5338-5348. [16] Sarhan AR, Patel TR, Creese AJ, Tomlinson MG, Hellberg C, Heath JK, Hotchin NA, Cunningham DL. Regulation of platelet derived growth factor signaling by Leukocyte Common Antigen-related (LAR) protein tyrosine phosphatase:a quantitative phosphoproteomics study[J]. Mol Cell Proteomics, 2016, 15:1823-1836. [17] Kartal O, Musabak U, Yesillik S, Sagkan RI, Pekel A, Demirel F, Baysan A, Selçuk A, Güleç M, Şener O. Killer-cell immunoglobulin-like receptor and human leukocyte antigen-C genes in common variable immunodeficiency[J]. Wien Klin Wochenschr, 2016, 128:822-826. [18] Ahmad W, Ijaz B, Shabbiri K, Ahmed F, Rehman S. Oxidative toxicity in diabetes and Alzheimer's disease:mechanisms behind ROS/RNS generation[J]. J Biomed Sci, 2017, 24:76. [19] Tönnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer's disease[J]. J Alzheimers Dis, 2017, 57:1105-1121. [20] Ilieva M, Nielsen J, Korshunova I, Gotfryd K, Bock E, Pankratova S, Michel TM. Artemin and an artemin-derived peptide, artefin, induce neuronal survival, and differentiation through ret and NCAM[J]. Front Mol Neurosci, 2019, 12:47. [21] Nencini S, Thai J, Ivanusic JJ. Sequestration of artemin reduces inflammation-induced activation and sensitization of bone marrow nociceptors in a rodent model of carrageenan-induced inflammatory bone pain[J]. Eur J Pain, 2019, 23:397-409. [22] Wang J, Wang H, Cai J, Du S, Xin B, Wei W, Zhang T, Shen X. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling[J]. Exp Cell Res, 2018, 365:12-23. [23] Nencini S, Ringuet M, Kim DH, Greenhill C, Ivanusic JJ. GDNF, neurturin, and artemin activate and sensitize bone afferent neurons and contribute to inflammatory bone pain[J]. J Neurosci, 2018, 38:4899-4911. [24] Song Z, Yang F, Du H, Li X, Liu J, Dong M, Xu X. Role of artemin in non-small cell lung cancer[J]. Thorac Cancer, 2018, 9:555-562. [25] Khosravi Z, Nasiri Khalili MA, Moradi S, Hassan Sajedi R, Zeinoddini M. The molecular chaperone artemin efficiently blocks fibrillization of TAU protein in vitro[J]. Cell J, 2018, 19:569-577. [26] Hezam K, Jiang J, Sun F, Zhang X, Zhang J. Artemin promotes oncogenicity, metastasis and drug resistance in cancer cells[J].Rev Neurosci, 2018, 29:93-98. |